Trastuzumab 440 mg Lyophilized Powder for IV Infusion

Send Inquiry

Request To Call Back

Trastuzumab 440 mg Lyophilized Powder for IV Infusion

Get a Price/Quote

MOQ : 100 Packs

Trastuzumab 440 mg Lyophilized Powder for IV Infusion Specification

Packaging Type
Single-dose vial

Life Span
24 months from date of manufacture

Origin of Medicine
India

Salt Composition
Trastuzumab 440 mg

Pacakaging (Quantity Per Box)
1 vial per box

Dosage Form
Injection, lyophilized powder

Indication
HER2-positive breast cancer, HER2-positive metastatic gastric cancer

Brand Name
Trastuzumab

Drug Type
Biological / Antibody therapy

Ingredients
Trastuzumab (recombinant humanized monoclonal antibody) as lyophilized powder

Physical Form
Lyophilized powder for IV infusion

Function
Antineoplastic (targeted therapy against HER2-overexpressing cancers)

Recommended For
Patients with HER2-positive breast cancer and metastatic gastric cancer

Dosage
440 mg per vial; dosing as per physicians protocol, often initial 8 mg/kg IV infusion followed by 6 mg/kg every 3 weeks

Dosage Guidelines
Dilute with sterile water before infusion; administered by healthcare professional

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store at 2C to 8C (36F to 46F), protect from light, do not freeze

Inactive Ingredients
L-histidine, L-histidine hydrochloride, trehalose, polysorbate 20

Box Contents
1 single-use vial + 20 mL bacteriostatic water for injection

Therapeutic Class
Monoclonal antibody, Antineoplastic

Contraindications
Known hypersensitivity to trastuzumab or its excipients

Administration Route
Intravenous infusion (not for IV push or bolus)

Concentration After Reconstitution
21 mg/mL

Reconstitution
Should be reconstituted with 20 mL bacteriostatic water for injection

Infusion Time
Initial dose over 90 minutes; subsequent doses may be given over 30 minutes if tolerated

Prescription Required
Yes

Regulatory Status
Prescription medicine, Schedule H

Appearance After Reconstitution
Clear to opalescent, colorless to pale yellow solution

Cautions
Monitor for infusion and cardiac-related reactions

Trastuzumab 440 mg Lyophilized Powder for IV Infusion Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
10 Days

Main Domestic Market
All India

About Trastuzumab 440 mg Lyophilized Powder for IV Infusion

Experience the sizzling efficacy of Trastuzumab 440 mg Lyophilized Powder for IV Infusion-a hot deal for patients seeking laureate cancer therapies. This praiseworthy monoclonal antibody targets HER2-positive breast and metastatic gastric cancers with outstanding precision. After fresh reconstitution with 20 mL bacteriostatic water, it yields a clear, potent solution, ideal for intravenous administration. Each single-use vial delivers 440 mg, ensuring quality and safety. Physicians value its proven results and its remarkable safety profile. Prescription required. Store at 2C to 8C, do not freeze.

Trastuzumab 440 mg: Application in Precision Oncology

Trastuzumab 440 mg Lyophilized Powder for IV Infusion is expertly used as a targeted monoclonal antibody therapy in oncology. Its application is paramount for patients diagnosed with HER2-positive breast and metastatic gastric cancers. Administered exclusively in clinical settings under strict medical supervision, it is pivotal in hospital oncology wards, cancer specialty clinics, and advanced treatment centers-delivering specialized, patient-focused care across India and globally.

Reliable Supply and Streamlined Delivery Across India

With outstanding supply ability, Trastuzumab 440 mg is available to meet rising oncology demands with minimal expenditure on logistics. Delivery time is prompt, maintaining the medicine's optimal condition and valuation, adhering to stringent cold chain protocols. The main domestic market spans major metropolitan and tier-1 cities across India, ensuring reliable access to this transformative biological therapy for healthcare facilities and cancer patients nationwide.

FAQ's of Trastuzumab 440 mg Lyophilized Powder for IV Infusion:

Q: How should Trastuzumab 440 mg Lyophilized Powder be prepared for infusion?

A: Trastuzumab 440 mg should be reconstituted with 20 mL of bacteriostatic water for injection. After gentle mixing, the lyophilized powder forms a clear to opalescent, colorless to pale yellow solution with a concentration of 21 mg/mL, suitable for intravenous infusion.

Q: What is the recommended administration route and infusion time for this medication?

A: Trastuzumab is administered only via intravenous infusion-never as an IV push or bolus. The initial dose should be infused over 90 minutes; if tolerated, subsequent doses can be administered over 30 minutes.

Q: When is Trastuzumab 440 mg indicated for use?

A: This medicine is indicated for adults with HER2-positive breast cancer and HER2-positive metastatic gastric cancer, providing targeted therapy where overexpression of the HER2 protein is confirmed.

Q: Where should Trastuzumab 440 mg be stored before use?

A: The vials must be refrigerated at 2C to 8C (36F to 46F), protected from light. They must not be frozen to preserve efficacy.

Q: What precautions should be taken during Trastuzumab infusion?

A: Patients must be monitored closely for infusion-related and cardiac events. Administration should be performed by healthcare professionals in suitable medical facilities to manage any adverse reactions promptly.

Tell us about your requirement